“So you put you put that combination together, David, of passing the headwinds of the VBP in China, and continue acceleration in the on all the other geographies. I I think diagnostics is set up for a nice for a nice recovery year next year.”

In context

“continue to see new business converting to Abbott Laboratories this year. So I think share gains in The U. S. Is really what's driving that. European region did very well too. The quarter. I think they were up six to 7% they're doing very well also. Then Latin America, for us is, you know, growing mid teens, consistently growing mid teens here also. So I think the dynamic is not changing. So we're not seeing the situation get get worse in China. And I think the teams are doing really well there. We'll be out of that next year and outside of China. I think the dynamic going exactly how we've expected them to go, which is Alinity is being rolled out. It's a very competitive system. The are hitting their stride here in various important geographies and like I said, I expect that to continue. So you put you put that combination together, David, of passing the headwinds of the VBP in China, and continue acceleration in the on all the other geographies. I I think diagnostics is set up for a nice for a nice recovery year next year. David Roman: Very helpful. And maybe just one follow-up here on on the P and L. I think in the gross margin line, there are probably a lot of moving parts as quarter around the first quarter burdening the impact of tariffs and then also probably some foreign exchange related dynamics on a move in the euro, for example. Can you maybe help us decompose a little bit sort of the operational performance in the P and L from some of those other other factors and how we should think about margin trajectory on a go forward basis? Robert Ford: Yeah. I'll ask Philip to take that one, Philip. Philip Boudreau: Yeah. Thanks, David. And and I think you touched on on the right elements there. Gross margin continues to be a key area of focus for us. We've spoken the past of the dedicated teams that we hav”